News | February 11, 2026
Wockhardt reports strong Q3 growth: revenue up 22%, EBITDA surges 72%
The company reported profit before tax of Rs.67 crore, up sharply from Rs.21 crore in the same period last year
The company reported profit before tax of Rs.67 crore, up sharply from Rs.21 crore in the same period last year
LIVMARLI’s new tablet form offers patients weighing 22 kg or more a convenient, one-tablet-per-dose option, complementing the existing 9.5 mg/ml oral solution
Inspection included drug device combinations covering our recent filing in nasal sprays domain
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
CSPC will receive an upfront $1.2 billion from AstraZeneca for access to eight programmes, AI molecular design capabilities, and the LiquidGel platform
Pangea will use its integrated validation platform and regulatory expertise to oversee analytical and clinical validation of Gene Solutions’ multi-omics technologies.
Plant 1 continues to serve as a core manufacturing hub for oral solid dosage forms
A dedicated Life Sciences Innovation Fund, scalable up to Rs. 1,000 crore, will catalyze early- and growth-stage innovation, support deep-tech ventures – particularly biotherapeutics
The acquisition marks a major step in PAI’s strategy to expand domestic pharmaceutical manufacturing
The current two-vial format requires healthcare professionals to mix a lyophilised antigen with a liquid adjuvant before administration
Subscribe To Our Newsletter & Stay Updated
